CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | Malecek Michael J Chief Legal Officer | Sale | −8,564 | $48.67 | $417K | 0 |
| 2023-03-15 | Malecek Michael J Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 125,000 | ||
| 2023-03-15 | Garren Hideki Chief Medical Officer | Option exercise | +12,000 | $24.90 | $299K | 12,000 |
| 2023-03-15 | Garren Hideki Chief Medical Officer | Sale | −6,000 | $48.16 | $289K | 6,000 |
| 2023-03-15 | Garren Hideki Chief Medical Officer | Sale | −6,000 | $48.66 | $292K | 0 |
| 2023-03-15 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −12,000 | 210,000 | ||
| 2023-03-02 | Malecek Michael J Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-02 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-02 | Smith Brandon S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-02 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-02 | Nguyen Tran Chief Strategy Officer and CFO | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-02 | Garren Hideki Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-02 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2023-03-02 | Walker Karin L Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2023-02-15 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +10,000 | $6.73 | $67K | 13,200 |
| 2023-02-15 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −9,336 | $53.30 | $498K | 3,864 |
| 2023-02-15 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −664 | $53.87 | $36K | 3,200 |
| 2023-02-15 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −10,000 | 10,000 | ||
| 2023-01-18 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +10,000 | $6.73 | $67K | 13,200 |
| 2023-01-18 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −7,277 | $55.18 | $402K | 5,923 |
Page 17 of 28 · 555 trades